OPPENHEIMER, FLORENCIA MAIA; PROIETTI, CECILIA JAZMÍN; CERUTI, JULIETA MARÍA; HAGELIN, KARIN; LEIRÓS, GUSTAVO JOSÉ; BALAÑÁ, MARÍA EUGENIA

Dermal papilla cells cultured as spheres improve angiogenesis

EXPERIMENTAL DERMATOLOGY; Año: 2024 vol. 33

BRUNI, SOFIA; MAURO, FLORENCIA L.; PROIETTI, CECILIA J.; CORDO-RUSSO, ROSALIA I.; RIVAS, MARTIN A.; INURRIGARRO, GLORIA; DUPONT, AGUSTINA; ROCHA, DARIO; FERNÁNDEZ, ELMER A.; DEZA, ERNESTO GIL; LOPEZ DELLA VECCHIA, DANIEL; BARCHUK, SABRINA; FIGURELLI, SILVINA; LASSO, DAVID; FRIEDRICH, ADRIÁN D.; SANTILLI, MARÍA C.; REGGE, MARÍA V.; LEBERSZTEIN, GABRIEL; LEVIT, CLAUDIO; ANFUSO, FABIANA; CASTIGLIONE, TERESA; ELIZALDE, PATRICIA V.; MERCOGLIANO, MARIA F.; SCHILLACI, ROXANA

Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression

Journal for ImmunoTherapy of Cancer; Año: 2023 vol. 11

SANTIAGO MADERA; FRANCO IZZO; MARIA FLORENCIA CHERVO; AGUSTINA DUPONT; VIOLETA CHIAUZZI; SOFIA BRUNI; EZEQUIEL PETRILLO; SHARON MERIN; MARA DE MARTINO; DIEGO MONTERO; CLAUDIO LEVIT; GABRIEL LEBERSZTEIN; FABIANA ANFUSO; AGUSTINA ROLDÁN DEAMICIS; FLORENCIA MERCOGLIANO; CECILIA J PROIETTI; ROXANA SCHILLACI; PATRICIA V ELIZALDE; ROSALIA INES CORDO RUSSO

Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer

Cell Death & Disease; Año: 2022

LEE, JI HOON; HONG, JUYEONG; ZHANG, ZHAO; DE LA PEÑA AVALOS, BÁRBARA; PROIETTI, CECILIA J.; DEAMICIS, AGUSTINA ROLDÁN; GUZMÁN G., PABLO; LAM, HUNG-MING; GARCIA, JOSE; ROUDIER, MARTINE P.; SISK, ANTHONY E.; DE LA ROSA, RICHARD; VU, KEVIN; YANG, MEI; LIAO, YIJI; SCHEIRER, JESSICA; PECHACEK, DOUGLAS; YADAV, POOJA; RAO, MANJEET K.; ZHENG, SIYUAN; JOHNSON-PAIS, TERESA L.; LEACH, ROBIN J.; ELIZALDE, PATRICIA V.; DRAY, ELOÏSE; XU, KEXIN

Regulation of telomere homeostasis and genomic stability in cancer by N 6 -adenosine methylation (m 6 A)

Science Advances; Año: 2021 vol. 7

MADERA, SANTIAGO; CHERVO, MARÍA F.; CHIAUZZI, VIOLETA A.; PEREYRA, MATÍAS G.; VENTURUTTI, LEANDRO; IZZO, FRANCO; ROLDÁN DEAMICIS, AGUSTINA; GUZMAN, PABLO; DUPONT, AGUSTINA; ROA, JUAN CARLOS; CENCIARINI, MAURO E.; BARCHUK, SABRINA; FIGURELLI, SILVINA; LOPEZ DELLA VECCHIA, DANIEL; LEVIT, CLAUDIO; LEBERSZTEIN, GABRIEL; ANFUSO, FABIANA; CASTIGLIONI, TERESA; CORTESE, EDUARDO; ARES, SANDRA; DEZA, ERNESTO GIL; GERCOVICH, FELIPE G.; PROIETTI, CECILIA J.; SCHILLACI, ROXANA; CORDO RUSSO, ROSALÍA I.; ELIZALDE, PATRICIA V.

Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good Prognosis

Hormones and Cancer; Año: 2020 vol. 11 p. 218 - 239

CHERVO, MARÍA F.; CORDO RUSSO, ROSALÍA I.; PETRILLO, EZEQUIEL; IZZO, FRANCO; DE MARTINO, MARA; BELLORA, NICOLÁS; CENCIARINI, MAURO E.; CHIAUZZI, VIOLETA A.; SANTA MARÍA DE LA PARRA, LUCÍA; PEREYRA, MATÍAS G.; GÜTTLEIN, LEANDRO N.; PODHAJCER, OSVALDO L.; DANIOTTI, JOSÉ L.; DUPONT, AGUSTINA; BARCHUK, SABRINA; FIGURELLI, SILVINA; LOPEZ DELLA VECCHIA, DANIEL; ROA, JUAN C.; GUZMÁN, PABLO; PROIETTI, CECILIA J.; SCHILLACI, ROXANA; ELIZALDE, PATRICIA V.

Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growth

ONCOGENE; Año: 2020

PATRICIA V ELIZALDE; CECILIA J PROIETTI

Steroid hormone receptors: A South American perspective

STEROIDS; Lugar: Amsterdam; Año: 2020 vol. 155

DE MARTINO, MARA; TKACH, MERCEDES; BRUNI, SOFÍA; ROCHA, DARÍO; MERCOGLIANO, MARÍA F.; CENCIARINI, MAURO E.; CHERVO, MARÍA F.; PROIETTI, CECILIA J.; DINGLI, FLORENT; LOEW, DAMARYS; FERNÁNDEZ, ELMER A.; ELIZALDE, PATRICIA V.; PIAGGIO, ELIANE; SCHILLACI, ROXANA

Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy

OncoImmunology; Año: 2020 vol. 9

MAURO EZEQUIEL CENCIARINI; CECILIA J PROIETTI

Molecular mechanisms underlying progesterone receptor action in breast cancer: Insights into cell proliferation and stem cell regulation.

STEROIDS; Lugar: Amsterdam; Año: 2019

CECILIA J PROIETTI; MAURO E CENCIARINI; PATRICIA V ELIZALDE

Revisiting Progesterone Receptor (PR) Actions in Breast Cancer: Insights into PR Repressive Functions

STEROIDS; Lugar: Amsterdam; Año: 2018

YANMING WU; ZHAO ZHANG; MAURO EZEQUIEL CENCIARINI; CECILIA J PROIETTI; MATIAS AMASINO; TAO HONG; MEI YANG; YIJI LIAO; HUAI-CHIN CHIANG; VIRGINIA KAKLAMANI; RINATH JESELSOHN; RATNA K. VADLAMUDI; TIM HUI-MING HUANG; RONG LI; CARMINE DE ANGELIS; XIAOYONG FU; PATRICIA V ELIZALDE; RACHEL SCHIFF; MYLES BROWN; KEXIN XU

Transcriptional Axis of EZH2-ER alpha;-GREB1 Regulates Tamoxifen Resistance in Breast Cancer

CANCER RESEARCH; Lugar: Philadelphia; Año: 2018

ROXANA SCHILLACI; FLORENCIA MERCOGLIANO; GLORIA INURRIGARRO; MARA DE MARTINO; LEANDRO VENTURUTTI; MARTIN RIVAS; ROSALIA INES CORDO RUSSO; CECILIA J PROIETTI; ELMER FERNANDEZ; ISABEL FRAHM; SABRINA BARCHUCK; DANIEL HORACIO ALLEMAND; SILVINA FIGURELLI; ERNESTO GIL DEZA; SANDRA ARES; FELIPE GERCOVICH; EDUARDO CORTESE; MATIAS AMASINO; PABLO GUZMAN; JUAN CARLOS ROA; PATRICIA V ELIZALDE

Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor response to trastuzumab in HER2-positive breast cancer

BMC CANCER; Lugar: Londres; Año: 2017

MERCOGLIANO, MARÍA F.; DE MARTINO, MARA; VENTURUTTI, LEANDRO; RIVAS, MARTÍN A.; PROIETTI, CECILIA J.; INURRIGARRO, GLORIA; FRAHM, ISABEL; ALLEMAND, DANIEL H.; DEZA, ERNESTO GIL; ARES, SANDRA; GERCOVICH, FELIPE G.; GUZMÁN, PABLO; ROA, JUAN C.; ELIZALDE, PATRICIA V.; SCHILLACI, ROXANA

TNFα-induced mucin 4 expression elicits trastuzumab resistance in HER2-positive breast cancer

CLINICAL CANCER RESEARCH; Año: 2017 vol. 23 p. 636 - 648

PATRICIA V. ELIZALDE; ROSALÍA I. CORDO RUSSO; MARIA FLORENCIA CHERVO; CECILIA J.PROIETTI; ROXANA SCHILLACI; EDUARDO H. CHARREAU

Efectos nucleares del receptor Tirosina Quinasa ErbB-2 en cancer de mama.

La Prensa Médica Argentina; Año: 2017

LEANDRO VENTURUTTI; ROSALIA CORDO RUSSO; MARTIN A RIVAS; MARIA FLORENCIA MERCOGLIANO; FRANCO IZZO; ROBERT H. OAKLEY; MATIAS PEREYRA; MARA DE MARTINO; CECILIA J PROIETTI; PATRICIO YANKILEVICH; JUAN CARLOS ROA; PABLO GUZMAN; EDUARDO CORTESE; DANIEL ALLEMAND; TIM H-M. HUANG; EDUARDO H CHARREAU; JOHN A. CIDLOWSKI; ROXANA SCHILLACI; PATRICIA V ELIZALDE

MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1

ONCOGENE; Lugar: Londres; Año: 2016

VENTURUTTI, L.; ROMERO, L.V.; URTREGER, A.J.; CHERVO, M.F.; CORDO RUSSO, R.I.; MERCOGLIANO, M.F.; INURRIGARRO, G.; PEREYRA, M.G.; PROIETTI, C.J.; IZZO, F.; DÍAZ FLAQUÉ, M.C.; SUNDBLAD, V.; ROA, J.C.; GUZMÁN, P.; BAL DE KIER JOFFÉ, E.D.; CHARREAU, E.H.; SCHILLACI, R.; ELIZALDE, P.V.

Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis

ONCOGENE; Año: 2016 vol. 35 p. 2208 - 2222

PROIETTI, CECILIA J.; IZZO, FRANCO; DÍAZ FLAQUÉ, MARÍA CELESTE; RUSSO, ROSALÍA CORDO; VENTURUTTI, LEANDRO; MERCOGLIANO, MARÍA FLORENCIA; DE MARTINO, MARA; PINEDA, VIVIANA; MUÑOZ, SERGIO; GUZMÁN, PABLO; ROA, JUAN C.; SCHILLACI, ROXANA; ELIZALDE, PATRICIA V.

Heregulin co-opts PR transcriptional action via stat3 role as a coregulator to drive cancer growth

MOLECULAR ENDOCRINOLOGY; Año: 2015 vol. 29 p. 1468 - 1485

FRANCO IZZO; FLORENCIA MERCOGLIANO; LEANDRO VENTURUTTI; MERCEDES TKACH; GLORIA INURRIGARRO; ROXANA SCHILLACI; LEANDRO CERCHIETTI; PATRICIA V ELIZALDE; CECILIA J PROIETTI

Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth

BREAST CANCER RESEARCH; Lugar: Londres; Año: 2014

ROSALÍA CORDO RUSSO; WENDY BÉGUELIN; MARÍA DÍAZ FLAQUÉ; CECILIA PROIETTI; LEANDRO VENTURUTTI; NATALIA GALIGNIANA; MERCEDES TKACH; PABLO GUZMÁN; JUAN ROA; NEIL O'BRIEN; EDUARDO CHARREAU; ROXANA SCHILLACI; PATRICIA V ELIZALDE

Targeting ErbB-2 Nuclear Localization and Function Inhibits Breast Cancer Growth and Overcomes Trastuzumab Resistance

ONCOGENE; Lugar: Londres; Año: 2014

MERCEDES TKACH, CINTHIA ROSEMBLIT, MARTÍN A. RIVAS, CECILIA J. PROIETTI , MARÍA C.DÍAZ FLAQUÉ, MARÍA FLORENCIA MERCOGLIANO, WENDY BEGUELIN, ESTEBAN MARONNA, PABLO GUZMÁN, FELIPE G. GERCOVICH, ERNESTO GIL DEZA, PATRICIA V. ELIZALDE , ROXANA SCHILLACI

P42/P44 MAPK-MEDIATED STAT3 SER727 PHOSPHORYLATION 1 IS REQUIRED FOR PROGESTIN-INDUCED FULL ACTIVATION OF STAT3 AND BREAST CANCER GROWTH

ENDOCRINE - RELATED CANCER; Lugar: Bristol; Año: 2013

DÍAZ FLAQUÉ C MARÍA; NATALIA M GALIGNIANA; WENDY BÉGUELIN; ROCIO VICARIO; CECILIA J PROIETTI; ROSALIA CORDO RUSSO; MARTIN A RIVAS; MERCEDES TKACH; PABLO GUZMAN; JUAN C ROA; ESTEBAN MARONNA; VIVIANA PINEDA; SERGIO MUÑOZ; FLORENCIA MERCOGLIANO; EDUARDO CHARREAU; PATRICIO YANKILEVICH; ROXANA SCHILLACI; PATRICIA V ELIZALDE

Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy

BREAST CANCER RESEARCH; Lugar: Londres; Año: 2013

MARÍA C DÍAZ FLAQUÉ, ROCIO VICARIO, CECILIA J PROIETTI, FRANCO IZZO, ROXANA SCHILLACI, PATRICIA V ELIZALDE.

Progestin drives breast cancer growth by inducing p21CIP1 expression through the assembly of a transcriptional complex among Stat3, progesterone receptor and ErbB-2

STEROIDS; Lugar: Amsterdam; Año: 2013 p. 559 - 567

ROBALDO L, IZZO F, DELLAFIORE M, PROIETTI C, ELIZALDE PV, MONTSERRAT JM, IRIBARREN AM.

Influence of conformationally restricted pyrimidines on the activity of 10-23 DNAzymes

BIOORGANIC & MEDICINAL CHEMISTRY.; Lugar: Amsterdam; Año: 2012 p. 2581 - 2586

SCHILLACI R.; GUZMAN P.; CAYROL, F.; BEGUELIN, W.; DIAZ FLAQUÉ, MC; PROIETTI, C.; PINEDA, V.; PALAZZI, J.; FRAHM, I.; CHARREAU, E. H.; MARONNA, E.; ROA, J. C.; ELIZALDE, P. V.

Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer

BMC CANCER; Lugar: Londres; Año: 2012 p. 12 - 74

PATRICIA V. ELIZALDE AND CECILIA J. PROIETTI

The Molecular Basis of Progesterone Receptor Action in Breast Carcinogenesis

Hormone Molecular Biology and Clinical Investigation; Año: 2012 vol. 9 p. 105 - 117

MERCEDES TKACH, LORENA CORIA, CINTHIA ROSEMBLIT, MARTıN A. RIVAS, CECILIA J. PROIETTI, MARıA CELESTE DıAZ FLAQUE´, WENDY BEGUELIN, ISABEL FRAHM, EDUARDO H. CHARREAU, JULIANA CASSATARO, PATRICIA V. ELIZALDE, AND ROXANA SCHILLACI

Targeting Stat3 Induces Senescence in Tumor Cells and Elicits Prophylactic and Therapeutic Immune Responses against Breast Cancer Growth Mediated by NK Cells and CD4+ T Cells

JOURNAL OF IMMUNOLOGY; Lugar: Bethesda; Año: 2012 p. 1162 - 1172

PROIETTI CJ, BÉGUELIN W, FLAQUÉ MC, CAYROL F, RIVAS MA, TKACH M, CHARREAU EH, SCHILLACI R, ELIZALDE PV

Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer.

STEROIDS; Año: 2011 p. 381 - 392

ELIZALDE PV, PROIETTI CJ, SCHILLACI R, BALAÑA ME, LABRIOLA L, SALATINO M, BÉGUELIN W, CARNEVALE R, DÍAZ FLAQUÉ C, CHARREAU EH

Interacciones entre factores de crecimiento (GFs) y el receptor de progesterona (PR) en cáncer de mama.

ACTA BIOQUíMICA CLíNICA LATINOAMERICANA; Lugar: La Plata; Año: 2011 p. 657 - 659

BÉGUELIN W, DÍAZ FLAQUÉ MC, PROIETTI CJ, CAYROL F, RIVAS MA, TKACH M, ROSEMBLIT C, TOCCI JM, CHARREAU EH, SCHILLACI R, ELIZALDE PV.

Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3.

MOLECULAR AND CELLULAR BIOLOGY; Año: 2010 p. 5456 - 5472

RIVAS MA, TKACH M, BEGUELIN W, PROIETTI CJ, ROSEMBLIT C, CHARREAU EH, ELIZALDE PV, SCHILLACI R.

Transactivation of ErbB-2 induced by tumor necrosis factor alpha promotes NF-kappaB activation and breast cancer cell proliferation.

BREAST CANCER RESEARCH AND TREATMENT; Año: 2009 p. 1 - 14

CECILIA J. PROIETTI,CINTHIA ROSEMBLIT, WENDY BEGUELIN, MARTÍN A. RIVAS, MARÍA CELESTE DÝAZ FLAQUE´, EDUARDO H. CHARREAU, ROXANA SCHILLACI, AND PATRICIA V. ELIZALDE

Activation of Stat3 by Heregulin/ErbB-2 through the Co-Option of Progesterone Receptor Signaling Drives Breast Cancer Growth

MOLECULAR AND CELLULAR BIOLOGY; Año: 2009 p. 1249 - 1265

MARTÍN A RIVAS; ROMINA P CARNEVALE; CECILIA J PROIETTI; CINTHIA ROSEMBLIT; MARIANA SALATINO; EDUARDO H CHARREAU, PETER BROUCKAERT, PATRICIA V ELIZALDE, ROXANA SCHILLACI

TNF-alpha acting on TNFR1 promotes breast cancer growth via p42/p44 MAPK, JNK, AKT and NF-Kappa B-dependent pathways

EXPERIMENTAL CELL RESEARCH; Año: 2008 p. 509 - 529

ROMINA P. CARNEVALE, CECILIA J. PROIETTI, MARIANA SALATINO, ALEJANDRO URTREGER, GUILLERMO PELUFFO, DEAN P. EDWARDS, VIROJ BOONYARATANAKORNKIT, EDUARDO H. CHARREAU, ELISA BAL DE KIER JOFFE´ , ROXANA SCHILLACI, PATRICIA V. ELIZALDE

Progestin Effects on Breast Cancer Cell Proliferation, Proteases Activation, and in Vivo Development of Metastatic Phenotype All Depend on Progesterone Receptor Capacity to Activate Cytoplasmic Signaling Pathways.

MOLECULAR ENDOCRINOLOGY; Año: 2007 p. 1335 - 1358

SCHILLACI R, SALATINO M, CASSATARO J, PROIETTI CJ, GIAMBARTOLOMEI GH, RIVAS MA, CARNEVALE RP, CHARREAU EH, ELIZALDE PV

Immunization with murine breast cancer cells treated with antisense oligodeoxynucleotides to type I insulin-like growth factor receptor induced an antitumoral effect mediated by a CD8+ response involving Fas/Fas ligand cytotoxic pathway

JOURNAL OF IMMUNOLOGY; Año: 2006 p. 3426 - 3437

SALATINO M, BEGUELIN W, PETERS MG, CARNEVALE R, PROIETTI CJ, GALIGNIANA MD, VEDOY CG, SCHILLACI R, CHARREAU EH, SOGAYAR MC, ELIZALDE PV

Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation

ONCOGENE; Año: 2006

PROIETTI CECILIA; SALATINO MARIANA; ROSEMBLIT CINTHIA; CARNEVALE ROMINA; PECCI ADALÍ; KORNBLIHTT ALBERTO R; MOLINOLO ALFREDO A; FRAHM ISABEL; CHARREAU EDUARDO H; SCHILLACI ROXANA AND ELIZALDE PATRICIA V

Progestins Induce Transcriptional Activation of Signal Transducer and Activator of Transcription 3 (Stat3) Via Jak and Src-Dependent Mechanism in Breast Cancer Cells

MOLECULAR AND CELLULAR BIOLOGY; Año: 2005 p. 4826 - 4840

SALATINO M, SCHILLACI R, PROIETTI C, CARNEVALE R, FRAHM I, MOLINOLO A, IRIBARREN A, CHARREAU E, ELIZALDE PV

Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor acti

ONCOGENE; Año: 2004 p. 5161 - 5174

SALATINO M, SCHILLACI R, PROIETTI CJ, CARNEVALE R, CHARREAU EH, ELIZALDE PV

Bloqueo del receptor del factor de crecimiento semejante a la insulina tipo I utilizando oligodeoxinucleótidos antisentido en cáncer de mama

MEDICINA; Año: 2004 p. 129 - 134

LABRIOLA L, SALATINO M, PROIETTI CJ, PECCI A, COSO O, KORNBLIHTT A, CHARREAU EH, ELIZALDE PV

Heregulin induces transcriptional activation of the Progesterone Receptor by a mechanism that requires functional ErbB-2 and MAPK activation in breast cancer cells

MOLECULAR AND CELLULAR BIOLOGY; Año: 2003 p. 1095 - 1111

L PURICELLI, C J PROIETTI, L LABRIOLA, M SALATINO, M E BALAÑÁ, J AGUIRRE GHISO, R LUPU, O P. PIGNATARO, E H. CHARREAU, E BAL DE KIER JOFFÉ, P V ELIZALDE

Heregulin inhibits proliferation via Erks and Phosphatidyl Inositol 3-kinase activation but regulates Urokinase Plasminogen Activator independently of these pathways in metastasic mammary tumor cells

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Año: 2002 p. 642 - 653